FOR HEMATOPOIETIC STEM CELLS SPECIFIC PROTEIN (HSI) AS A MARKER FOR MALIGNE LYMPHOME

摘要

Use of a phosphorylated form of hematopoietic-lineage-cell-specific-protein-1 (HS1) as a prognostic or diagnostic marker for a Lymphoid Malignancy, a disease in which B cell receptor stimulation is dysregulated or disease characterised by B lymphocyte proliferation.